Effect of GE-132 on the Hepatic Bromobenzene Metabolizing Enzyme System in Rats

유기게르마늄(GE-132)이 Bromobenzene의 대사계에 미치는 영향

  • Published : 1993.12.01

Abstract

The study was attempted to elucidate the mechanism of GE-132(100mg/kg, p.o. for 6 weeks) on the metabolism of bromobenzene (460mg/kg, i.p. bid, for 2 days), which has potent carcinogenicity, mutagenicity and hepatotoxicity. It showed that activities of cytochrome p-450, aminopyrine demethylase and aniline hydroxylase, which have epoxide generating property, were not changed by GE-132 treatment. On the other hand, epoxide hydrolase was not changed but that glutathione S-transferase was significantly increased by GE-132 treatment. And also ${\gamma}-glutamylcysteine$ synthetase was not changed following the GE-132 treatment, but the activity of glutathione reductase was significantly increased. The level of hepatic glutathione which was decreased by bromobenzene recovered markedly by GE-132 pretreatment. It is concluded that the mechanism for the observed effect of GE-132 on bromobenzene metabolism is due to the induction of glutathione S-transferase.

Bromobenzene투여시 GE-132의 해독기전을 추구할 목적으로 epoxide생성계와 해독계 효소 및 glutathione 관련 효소계의 활성에 GE-132가 어떤 영향을 주는가를 검토하여 다음과 같은 실험 결과를 얻었다. GE-132(100mg/kg)의 전처리로 cytochrome P-450, amino=pyrine demethylase 및 aniline hydroxylase와 해독계 효소인 epoxide hydrolase활성에는 영향을 미치지 않았으나, glutathions S-transferase활성은 증가 하였다. Bromobenzene(460mg/kg)을 주사하였을때 glutathione S-transferase의 활성이 현저히 감소되던 것이 GE-132의 투여로 대조군 수준으로 증가되었다. 조직내 glutathione의 함량변동도 bromobenzene 투여로 감소되던 것이 GE-132의 전처리로 bromobenzene단독 투여군보다 증가되었으며 ${\gamma}-glutamylcystein$ synthtase의 활성은 각 실험군에서 별다른 영향이 없는데 비해 glutathione reductase의 활성은 bromobenzene투여로 억제 되던 것이 GE-132의 전처리로 대조군 수준으로 활성을 유지하고 있었다.

Keywords

References

  1. Proceedings of the 21st Annual Meeting of Japan Chemical Society Synthesis of carboxyethlylgermanium sesquioxide compound Oikawa,H.;Kakimoto,N.
  2. Proc. Jpn. Cancer Assoc. Ⅱ. Annual Meeting Antitumor effects of organogermanium compound(GE-132) in mouse tumors Ishida,N.;Suzuki,F.;Hayashi,Y.
  3. Int. J. Radiat. Biol. v.42 no.6 Antimutagenic effect of GE-132 on γ-ray-induced mutation in Escherichia coli B/rWP2trp- Mochizuki,H.;Kada,T.
  4. Anticancer Res. v.62 no.2 Cooperation of lymphokine(s) and marcrophages in expression of antitumor activity of carboxyethylgermanium(GE-132) Suzuki,F.;Brutkiewicz,R.R.;Pollard,R.B.
  5. J. Pharmacol. Exp. Ther. v.236 no.1 Antiarthritic and immunoregulatory activity of spirogermanium DiMartino,M.J.
  6. J. Biol. Respose Mod. v.8 no.2 Antivial activity of carboxyethylgermanium sesquioxide (GE-132) in mice infected with influenza virus Aso,H.;Suzuki,F.;Ebina,T.;Ishida,N.
  7. Biotechnol. Appl. Biochem. v.8 Inhibitory effects of GE-132 derivatives on enkephalin-degrading enzymes Komuro,T.;Kaimoto,N.;Katayama,T.;Hazato,T.
  8. 1st Int. Conf. on germanium, Hanover, Oct. 1984 Glutathione and glutathione-dependent enzymes of the rat liver after different doses of Sanumgerman Harisch,G.;Ledin(ed.);Samochowiec(ed.)
  9. Yakhak Hoeji v.35 no.2 Effect of organic germanium on metallothionein induction in liver and kidney of cadnium and mercury intoxicated rats Lee,H.M.;Chung,Y.
  10. Heterocyclic compounds with three and four-membered rings Rosowsky,A.;Weissberger(ed.)
  11. Biochem. Biophys. Acta. v.151 Labelling of the active center of a beta-glucosidase Legler,G.
  12. Nature v.22 Specific and irreversible inhibition of lysozyme by 2', 3' -epoxypropyl-beta-glycosides of N-acetyl-O-glucosamine oligomers Thomas,W.E.;Mekeluy,J.F.;Shorn,N.
  13. Drug Exp. Clin. Res. v.8 Epoxypeptides, a novel group of metabolic inhibitors in prokaryotic and eukaryotic micro-organisms Milewski,C.H.;Dzieduszycka,M.;Smulkowski,M.;Sawlewicz,P.;Borowski,E.
  14. Cancer. Res. v.42 Induction of microsomal enzymes by foreign chemical and carcinogenesis by polycyclic aromatic hydrocarbons Conney,A.H.
  15. Biochem. Pharmacol. v.31 Reactive metabolism and carcinogenicity of halogenated ethylenes Bolt,H.M.;Laib,R.J.;Filser,J.G.
  16. Biochem. Pharmacol. v.32 Structure-genotoxicity relationships for aliphatic epoxides Jones,R.B.;Machrodt,W.C.
  17. Proc. Nat. Acad. Sci. v.68 Possible mechanism of liver necrosis caused by aromatic organic compounds Brodie,B.B.;Reid,W.D.;Cho.A.K.;Sipes,G.;Gillette,J.R.
  18. Pharmacology v.6 Bromobenzene metabolism and hepatic necrosis Reid,W.D.;Cristie,B.;Krishma,G.;Mitchell,J.R.;Brovie,B.B.
  19. J. Orthomol. Medicine v.1 no.3 Oxygen-nutrition for super health Levine,S.A.;Kidd,P.M.
  20. J. Pharmacol. Exp. Ther. v.187 Role of detoxifying enzymes in bromobenzene-induced liver necrosis Zampaglione,N.;Jollow,D.J.;Mitchell,J.R.;Manrick,M.;Gillette,J.R.
  21. J. Biol. Chem. v.239 The carbon monoxide bindings pigments of liver microsomes. 1. Evidence for its hemoprotein nature Omura,T.;Sato,T.
  22. J. Biol. Chem. v.55 The colorimetric estimation of formaldehyde by means of the hantzsch reaction Nash,T.
  23. Biochem. Pharmocol. v.31 Multiple drug metabolism : ρ-nitroanisole reversal of acetone enhanced aniline hydroxylation Bidlack,W.R.;Lowery,G.L.
  24. Biochem. Pharmacol. v.31 no.11 Spectrophotometric assay for mammlian cytosolic epoxide hydrofase using-stilbene oxide as the substrate Hasegawa,L.S.;Hammock,B.D.
  25. J. Biol. Chem. v.249 Glutathione S-transferase;The fisrt step in mercapturate acid formation Habig,W.H.;Pabist,M.J.;Jakoby,W.B.
  26. J. Biol. Chem. v.250 Regeneration of γ-glutamylcystein synthetase by nonallosteric feedback inhibition by glutathione Meister,A.;Richman,P.G.
  27. J. Biol. Chem. v.237 Hepatic glutathione reductase : Ⅰ. purification and general kinetic properties Mize,C.E.;Langdon,R.G.
  28. Arch. Biochem. Biophys. v.82 Tissue sulfhydryl group Ellman,G.L.
  29. Registry of toxic effects of chemical substance Doris,V.S.
  30. J. Biol. Chem. v.193 Protein measurement with folin phenol reagent Lowry,O.H.;Rosebrough,N.H.;Farr,A.L.;Randall,R.J.
  31. a Lange medical book(5th ed.) Basic and clinical pharmacology Bertram,G.K.
  32. Toxicol. Lett. v.20 Nephrotoxicity of bromobenzene in mice Rush,G.F.;Kuo,C.H.;Hook,J.B.
  33. Drug. Metab. Dispos. v.13 Glutathione conjugates of 2-bromohydroquinone are nephrotoxic Monks,T.J.;Lau,S.S.;Highet,R.J.;Gillette,J.R.
  34. Biochem. Biophys. Acta. v.618 Rat hepatic cytosolic glutathione dependent enzyme protection against lipid peroxidation in the NADPH-microsomal lipid peroxidation system Burk,R.F.;Trumble,M.J.;Lawrence,R.A.
  35. Biochem. Biophys. Res. Commun. v.101 Evidence for the occurence of selenium-independent glutathione peroxidase activity in rat liver microsome Reddy,C.C.;Tu,C.P.D;Burgess,J.R.;Ho,C.Y.;Scholz,R.W.;Massaro,E.J.
  36. Science v.220 Selective modification of glutathione metabolism Meister,A.